MCK McKesson Corporation
Trend channel, buy level and 3-month target. Information only, not financial advice.
At the channel ceiling · 9-month channel rising
Price is at the upper line, where it has stalled before.
- 9-month channel
- US$884.09 – US$972.04 · rising, +8% a year
- Price in channel
- 127% (0% = floor, 100% = ceiling)
- Ceiling overhead
- none — above both ceilings
- Turns bearish below
- US$884.09
- Published levels
- Buy and target are not from this channel — see below.
Price history, with the path projected 3 months forward
Updated 8:15 PM ET (40 h ago)
- Daily close
- Upper trend line (9 months)
- Lower trend line (9 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Suggested path
Buy at or below
US$903.89
level as at 1 Dec 2026
Our target
US$997.24
by 8 Jan 2027
Projected move
10.3%
gross, before costs
Price is between our buy and target.
Target: the next swing high.
This move size: reached in 65% of 9 past stretches, typically in 70 days. (0.15% per day)
- Upper line touches
- 2
- Lower line touches
- 4
- Fit confidence
- 78%
- Fitted
- 1 Nov 2026
Company information
About McKesson Corporation
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Brian S. Tyler
- Employees
- 42,300
- Country
- US
Scorecard
Our own scores from the fundamentals below (not Morningstar ratings).
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$115.96B
- Enterprise value
- —
- Beta
- 0.30
- Avg volume
- 921.00K
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 723.68-1030.27
- Exchange
- NYSE
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.